Key Details
Price
$8.37Last Dividend
$0.25TTM Dividend Yield
2.99%Annual ROE
86.32%Beta
0.17Events Calendar
Next earnings date:
Feb 28, 2025Recent quarterly earnings:
Oct 15, 2024Recent annual earnings:
Feb 28, 2024Next ex-dividend date:
Feb 14, 2025Recent ex-dividend date:
Nov 15, 2024Next split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Aug 29, 22 Maxim Group
BuyMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Events
Dividend per share
Dividend yield
Other
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
Cord Blood Banking Leader Cryo-Cell Reports Fiscal Third Quarter 2024 Financial Results
CCEL
businesswire.comOctober 15, 2024
OLDSMAR, Fla.--(BUSINESS WIRE)--Cryo-Cell International, Inc. (NYSE American LLC Symbol: CCEL) (the “Company”), the world's first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal third quarter ended August 31, 2024. Financial Results Revenue Consolidated revenues for the third quarter of fiscal 2024 were $8.07 million compared to $7.87 million for the third quarter of fiscal 2023. Net Income The Company reported net income for the three months e.
FAQ
- What is the ticker symbol for Cryo-Cell International?
- Does Cryo-Cell International pay dividends?
- What sector is Cryo-Cell International in?
- What industry is Cryo-Cell International in?
- What country is Cryo-Cell International based in?
- When did Cryo-Cell International go public?
- Is Cryo-Cell International in the S&P 500?
- Is Cryo-Cell International in the NASDAQ 100?
- Is Cryo-Cell International in the Dow Jones?
- When was Cryo-Cell International's last earnings report?
- When does Cryo-Cell International report earnings?
- Should I buy Cryo-Cell International stock now?
What is the ticker symbol for Cryo-Cell International?
The ticker symbol for Cryo-Cell International is NASDAQ:CCEL
Does Cryo-Cell International pay dividends?
Yes, Cryo-Cell International pays dividends. The last payment was $0.25, with an ex-dividend date on November 15, 2024
What sector is Cryo-Cell International in?
Cryo-Cell International is in the Healthcare sector
What industry is Cryo-Cell International in?
Cryo-Cell International is in the Medical Care Facilities industry
What country is Cryo-Cell International based in?
Cryo-Cell International is headquartered in United States
When did Cryo-Cell International go public?
Cryo-Cell International's initial public offering (IPO) was on April 4, 1994
Is Cryo-Cell International in the S&P 500?
No, Cryo-Cell International is not included in the S&P 500 index
Is Cryo-Cell International in the NASDAQ 100?
No, Cryo-Cell International is not included in the NASDAQ 100 index
Is Cryo-Cell International in the Dow Jones?
No, Cryo-Cell International is not included in the Dow Jones index
When was Cryo-Cell International's last earnings report?
Cryo-Cell International's most recent earnings report was on Oct 15, 2024
When does Cryo-Cell International report earnings?
The next expected earnings date for Cryo-Cell International is Feb 28, 2025
Should I buy Cryo-Cell International stock now?
As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions